A qualitative study evaluating experiences of a lifestyle intervention in men with prostate cancer undergoing androgen suppression therapy
Open Access
- 14 November 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Trials
- Vol. 13 (1), 208
- https://doi.org/10.1186/1745-6215-13-208
Abstract
Background The severe iatrogenic hypogonadal state induced by medical castration used for treatment of prostate cancer is associated with adverse effects including fatigue, increased fracture risk, and a decrease in skeletal muscle function, which negatively impact quality of life. We have previously reported beneficial changes in healthy lifestyle behaviors, physical function and fatigue as a result of a novel combined exercise and dietary advice intervention (a lifestyle intervention) in men with prostate cancer on androgen suppression therapy (AST). The aim of this research was to conduct a qualitative evaluation of the lifestyle intervention in these men with advanced prostate cancer receiving androgen suppression therapy (AST). Methods Twelve men with prostate cancer on AST took part in three focus groups in a UK higher education institution following the 12 week intervention. Sessions lasted between 45 and 60 minutes in duration. All discussions were audio-taped and transcribed. A framework analysis approach was applied to the focus group data. An initial coding framework was developed from a priori issues listed in the topic guide and extended and refined following initial familiarization with the focus group transcripts. Line by line indexing of the transcripts was undertaken iteratively to allow for the incorporation of new codes. Coded sections of text were grouped together (charted) into themes and subthemes prior to a further process of comparison and interpretation. Results None of the participants involved in the trial were provided with information on how lifestyle changes might be beneficial to men with prostate cancer during the course of their standard medical treatment. We present novel findings that this intervention was considered beneficial for reducing anxiety around treatment and fear of disease progression. Men were supportive of the benefits of the intervention over conventional cancer survival discussion group arrangements as it facilitated peer support in addition to physical rehabilitation. Conclusions The benefits of lifestyle changes in men with prostate cancer are not well appreciated by care providers despite a range of benefits becoming apparent. Strategies to implement exercise and dietary interventions in standard care should be further evaluated. Trial registration Current Controlled Trials ISRCTN88605738 Keywords: Prostate cancer; Androgen suppression; Exercise; Diet; Rehabilitation; Patient evaluatioKeywords
This publication has 33 references indexed in Scilit:
- Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping reviewBritish Journal of Cancer, 2011
- The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivorsBritish Journal of Cancer, 2011
- Physical Activity after Diagnosis and Risk of Prostate Cancer Progression: Data from the Cancer of the Prostate Strategic Urologic Research EndeavorCancer Research, 2011
- Lifestyle Intervention in Men with Advanced Prostate Cancer Receiving Androgen Suppression Therapy: A Feasibility StudyCancer Epidemiology, Biomarkers & Prevention, 2011
- Physical Activity and Survival After Prostate Cancer Diagnosis in the Health Professionals Follow-Up StudyJournal of Clinical Oncology, 2011
- Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled TrialJournal of Clinical Oncology, 2010
- Cancer prevalence in the United Kingdom: estimates for 2008British Journal of Cancer, 2009
- ‘Getting through’ not ‘going under’: A qualitative study of gender and spousal support after diagnosis with colorectal cancerSocial Science & Medicine (1982), 2009
- Gonadotropin-Releasing Hormone Agonists and Fracture Risk: A Claims-Based Cohort Study of Men With Nonmetastatic Prostate CancerJournal of Clinical Oncology, 2005
- Adult cancer survivors: How are they faring?Cancer, 2005